BioNexus Gene Lab Corp. (BGLC) vs Top KingWin Ltd. Class A (DPU)
A side-by-side comparison of BioNexus Gene Lab Corp. and Top KingWin Ltd. Class A across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGLC
BioNexus Gene Lab Corp.
$1.21IndustrialsDelayed quote: Oct 6, 2026, 9:30 AM EDT
DPU
Top KingWin Ltd. Class A
$1.36IndustrialsDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — BGLC vs DPU
growth of $100 · dividends reinvested · last 3yBGLC -96.5% (-67.4%/yr)DPU -99.9% (-91.9%/yr)BGLC compounded faster over this window
Log scale — wide-divergence pair
BGLC DPU
BGLC vs DPU: by the numbers
- •BGLC is the larger company ($3M vs $3M market cap).
- •Both run net losses; BGLC's is the smaller (-82.36% vs -298.83% net margin).
- •Both shrank revenue over the past five years; DPU's decline was smaller (-3.47% vs -31.68% CAGR).
Metrics side by side
Valuation
| Metric | BGLC | DPU |
|---|---|---|
| P/S ratio | 0.94 | N/A |
| P/B ratio | 0.38 | N/A |
Profitability
| Metric | BGLC | DPU |
|---|---|---|
| Gross margin | 11.64% | 7.66% |
| Operating margin | -42.54% | -301.60% |
| Net margin | -82.36% | -298.83% |
| ROE | -33.11% | -76.99% |
| ROIC | -32.71% | -77.71% |
Growth (annualized)
| Metric | BGLC | DPU |
|---|---|---|
| Revenue CAGR (5Y) | -31.68% | -3.47% |
| Total return CAGR (5Y) | -61.00% | N/A |
Frequently asked
- Which has grown faster, BGLC or DPU?
- Neither grew: over the past five years both shrank revenue, with DPU's decline the smaller — BGLC at a -31.68% CAGR versus DPU at -3.47%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.